These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11755457)

  • 21. Validation of the Cohen-Mansfield Agitation Inventory Observational (CMAI-O) tool.
    Griffiths AW; Albertyn CP; Burnley NL; Creese B; Walwyn R; Holloway I; Safarikova J; Surr CA
    Int Psychogeriatr; 2020 Jan; 32(1):75-85. PubMed ID: 30968783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of behavioral symptoms in community-dwelling dementia patients.
    Weiner MF; Williams B; Risser RC
    Am J Geriatr Psychiatry; 1997; 5(1):26-30. PubMed ID: 9169242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine Comparative Trial study).
    Yoon SJ; Choi SH; Na HR; Park KW; Kim EJ; Han HJ; Lee JH; Shim YS; Na DL
    Geriatr Gerontol Int; 2017 Mar; 17(3):494-499. PubMed ID: 27111084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying behavioral disturbance in Alzheimer's disease patients.
    Weiner MF; Tractenberg R; Teri L; Logsdon R; Thomas RG; Gamst A; Thal LJ
    J Psychiatr Res; 2000; 34(2):163-7. PubMed ID: 10758259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing neuropsychiatric symptoms in nursing home patients with dementia: reliability and Reliable Change Index of the Neuropsychiatric Inventory and the Cohen-Mansfield Agitation Inventory.
    Zuidema SU; Buursema AL; Gerritsen MG; Oosterwal KC; Smits MM; Koopmans RT; de Jonghe JF
    Int J Geriatr Psychiatry; 2011 Feb; 26(2):127-34. PubMed ID: 20690131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability and validity of the Japanese version of the Agitated Behaviour in Dementia Scale in Alzheimer's disease: three dimensions of agitated behaviour in dementia.
    Torii K; Nakaaki S; Banno K; Murata Y; Sato J; Tatsumi H; Yamanaka K; Narumoto J; Mimura M; Akechi T; Furukawa TA
    Psychogeriatrics; 2011 Dec; 11(4):212-20. PubMed ID: 22151240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Confirmatory and an Exploratory Factor Analysis of the Cohen-Mansfield Agitation Inventory (CMAI) in a European Case Series of Patients with Dementia: Results from the RECage Study.
    Cesana BM; Poptsi E; Tsolaki M; Bergh S; Ciccone A; Cognat E; Fabbo A; Fascendini S; Frisoni GB; Frölich L; Jori MC; Mecocci P; Merlo P; Peters O; Defanti CA
    Brain Sci; 2023 Jul; 13(7):. PubMed ID: 37508955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor Analysis of the Short-Form Cohen-Mansfield Agitation Inventory and the Measurement Invariance by Gender.
    Paudel A; Resnick B; Galik E
    J Nurs Meas; 2021 Dec; 29(3):523-540. PubMed ID: 34518408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral and psychological symptoms and the progression of dementia of the Alzheimer type in nursing home residents.
    Bidzan L; Pachalska M; Grochmal-Bach B; Bidzan M; Jastrzebowska G
    Med Sci Monit; 2008 Nov; 14(11):CR559-67. PubMed ID: 18971872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
    De Deyn PP; Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():19-22. PubMed ID: 11584983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial.
    Mowla A; Pani A
    J Clin Psychopharmacol; 2010 Feb; 30(1):40-3. PubMed ID: 20075646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability and validity of the Norwegian version of the Brief Agitation Rating Scale (BARS) in dementia.
    Sommer OH; Engedal K
    Aging Ment Health; 2011 Mar; 15(2):252-8. PubMed ID: 21140306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agitation in Dutch institutionalized patients with dementia: factor analysis of the Dutch version of the Cohen-Mansfield Agitation Inventory.
    Zuidema SU; de Jonghe JF; Verhey FR; Koopmans RT
    Dement Geriatr Cogn Disord; 2007; 23(1):35-41. PubMed ID: 17077631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of aggressive behaviors in dementia: comparison of the physical aggression subscales of the Cohen-Mansfield Agitation Inventory and the Ryden Aggression Scale.
    Whall AL; Kim H; Colling KB; Hong GR; DeCicco B; Antonakos C
    Res Gerontol Nurs; 2013 Jul; 6(3):171-7. PubMed ID: 23550812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender differences in clusters of NPS in Dutch nursing homes - a factor analysis.
    Ho J; Wetzels RB; Bor H; Zuidema SU
    Int Psychogeriatr; 2016 Dec; 28(12):1989-1999. PubMed ID: 27572478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type.
    Fujikawa T; Takahashi T; Kinoshita A; Kajiyama H; Kurata A; Yamashita H; Yamawaki S
    Neuropsychobiology; 2004; 49(4):201-4. PubMed ID: 15118358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validity and responsiveness to change of clinically derived MDS scales in Alzheimer disease outcomes research.
    Smart KA; Herrmann N; Lanctôt KL
    J Geriatr Psychiatry Neurol; 2011 Jun; 24(2):67-72. PubMed ID: 21460341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults.
    Van der Mussele S; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Mar; 28(3):265-75. PubMed ID: 22549770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.